311 related articles for article (PubMed ID: 16682712)
1. Current management of the complications of portal hypertension: variceal bleeding and ascites.
Dib N; Oberti F; Calès P
CMAJ; 2006 May; 174(10):1433-43. PubMed ID: 16682712
[TBL] [Abstract][Full Text] [Related]
2. Management of portal hypertension in children.
Mileti E; Rosenthal P
Curr Gastroenterol Rep; 2011 Feb; 13(1):10-6. PubMed ID: 20927620
[TBL] [Abstract][Full Text] [Related]
3. Diagnosis, prevention and treatment of hepatorenal syndrome in cirrhosis.
Salerno F; Gerbes A; Ginès P; Wong F; Arroyo V
Gut; 2007 Sep; 56(9):1310-8. PubMed ID: 17389705
[No Abstract] [Full Text] [Related]
4. Diagnosis and Management of Cirrhosis and Its Complications: A Review.
Tapper EB; Parikh ND
JAMA; 2023 May; 329(18):1589-1602. PubMed ID: 37159031
[TBL] [Abstract][Full Text] [Related]
5. Pathophysiology and therapeutic options for cirrhotic portal hypertension.
Guixé-Muntet S; Quesada-Vázquez S; Gracia-Sancho J
Lancet Gastroenterol Hepatol; 2024 Jul; 9(7):646-663. PubMed ID: 38642564
[TBL] [Abstract][Full Text] [Related]
6. Review article: Recent advances in ascites and acute kidney injury management in cirrhosis.
Adebayo D; Wong F
Aliment Pharmacol Ther; 2024 May; 59(10):1196-1211. PubMed ID: 38526023
[TBL] [Abstract][Full Text] [Related]
7. Oxidative Mechanisms and Cardiovascular Abnormalities of Cirrhosis and Portal Hypertension.
Liu H; Nguyen HH; Hwang SY; Lee SS
Int J Mol Sci; 2023 Nov; 24(23):. PubMed ID: 38069125
[TBL] [Abstract][Full Text] [Related]
8. Subcutaneous therapy for portal hypertension: PHIN-214, a partial vasopressin receptor 1A agonist.
Castillo GM; Yao Y; Guerra RE; Jiang H; Nishimoto-Ashfield A; Lyubimov AV; Alfaro JF; Striker KA; Buynov N; Schwabl P; Bolotin EM
Biomed Pharmacother; 2024 Feb; 171():116068. PubMed ID: 38176129
[TBL] [Abstract][Full Text] [Related]
9. Regression of portal hypertension: underlying mechanisms and therapeutic strategies.
Selicean S; Wang C; Guixé-Muntet S; Stefanescu H; Kawada N; Gracia-Sancho J
Hepatol Int; 2021 Feb; 15(1):36-50. PubMed ID: 33544313
[TBL] [Abstract][Full Text] [Related]
10. Expert perspectives for the pharmacist on facilitating and improving the use of albumin in cirrhosis.
Kugelmas M; Loftus M; Owen EJ; Wadei H; Saab S
Am J Health Syst Pharm; 2023 Jun; 80(13):806-817. PubMed ID: 37013893
[TBL] [Abstract][Full Text] [Related]
11. Ascites, refractory ascites and hyponatremia in cirrhosis.
Fortune B; Cardenas A
Gastroenterol Rep (Oxf); 2017 May; 5(2):104-112. PubMed ID: 28533908
[TBL] [Abstract][Full Text] [Related]
12. Inflammation: a way to understanding the evolution of portal hypertension.
Aller MA; Arias JL; Cruz A; Arias J
Theor Biol Med Model; 2007 Nov; 4():44. PubMed ID: 17999758
[TBL] [Abstract][Full Text] [Related]
13. Gut-Liver Axis Dysregulation in Portal Hypertension: Emerging Frontiers.
Lombardi M; Troisi J; Motta BM; Torre P; Masarone M; Persico M
Nutrients; 2024 Apr; 16(7):. PubMed ID: 38613058
[TBL] [Abstract][Full Text] [Related]
14. Management of cirrhotic ascites.
Pedersen JS; Bendtsen F; Møller S
Ther Adv Chronic Dis; 2015 May; 6(3):124-37. PubMed ID: 25954497
[TBL] [Abstract][Full Text] [Related]
15. A Rare Case of Portal Hypertension and Ascites Following Intrauterine Fetal Death: A Case Report.
Shah AA; Priyatha V; Ali Y; Wahab A; Salarzai MA; Ahmad J; Salih N
Cureus; 2024 Mar; 16(3):e55364. PubMed ID: 38562337
[TBL] [Abstract][Full Text] [Related]
16. Management of hepatic hydropericardium with open drainage, maximal medical therapy and terlipressin.
Ermongkonchai T; Ha P; French J
BMJ Case Rep; 2024 Jan; 17(1):. PubMed ID: 38216161
[TBL] [Abstract][Full Text] [Related]
17. Pathophysiology of ascites: The importance of the intestine. A surgical contribution to the understanding of a medical problem.
Gondolesi GE; Rumbo C; Montes L; Novellis L; Ramisch D; Henríquez AR; Ortega M; Viano F; Schiano T; Descalzi V; Tiribelli C; Oltean M; Barros-Schelotto P; Solar H
Ann Hepatol; 2024; 29(3):101498. PubMed ID: 38479458
[TBL] [Abstract][Full Text] [Related]
18. Management of ascites and hepatorenal syndrome.
Piano S; Tonon M; Angeli P
Hepatol Int; 2018 Feb; 12(Suppl 1):122-134. PubMed ID: 28836115
[TBL] [Abstract][Full Text] [Related]
19. Portal hypertension and its complications.
Blei AT
Curr Opin Gastroenterol; 2007 May; 23(3):275-82. PubMed ID: 17414843
[TBL] [Abstract][Full Text] [Related]
20. Purastat as an Adjunct Treatment Option in Acute Esophageal Varices Bleeding: A Case Report.
Hassan IH; Elphick D; Al-Rifaie A
Cureus; 2023 Jul; 15(7):e42712. PubMed ID: 37529804
[TBL] [Abstract][Full Text] [Related]
[Next] [New Search]
